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Abstract
One characteristic of tumor microenvironment is oxygen fluctuation, which results from hyper-proliferation and abnormal
metabolism of tumor cells as well as disorganized neo-vasculature. Reoxygenation of tumors can induce oxidative stress,
which leads to DNA damage and genomic instability. Although the cellular responses to hypoxia are well known, little is
known about the dynamic response upon reoxygenation. In order to investigate the transcriptional responses of tumor
adaptation to reoxygenation, breast cancer MCF-7 cells were cultured under 0.5% oxygen for 24 h followed by 24 h of
reoxygenation in normoxia. Cells were harvested at 0, 1, 4, 8, 12, and 24 h during reoxygenation. The transcriptional profile
of MCF-7 cells upon reoxygenation was examined using Illumina Human-6 v3 BeadChips. We identified 127 differentially
expressed genes, of which 53.1% were up-regulated and 46.9% were down-regulated upon reoxygenation. Pathway
analysis revealed that the HIF-1-alpha transcription factor network and validated targets of C-MYC transcriptional activation
were significantly enriched in these differentially expressed genes. Among these genes, a subset of interest genes was
further validated by quantitative reverse-transcription PCR. In particular, human N-MYC down-regulated gene 1 (NDRG1)
was highly suppressed upon reoxygenation. NDRG1 is associated with a variety of stress and cell growth-regulatory
conditions. To determine whether NDRG1 plays a role in reoxygenation, NDRG1 protein was overexpressed in MCF-7 cells.
Upon reoxygenation, overexpression of NDRG1 significantly inhibited cell migration. Our results revealed the dynamic
nature of gene expression in MCF-7 cells upon reoxygenation and demonstrated that NDRG1 is involved in tumor
adaptation to reoxygenation.
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Introduction
Tumor populations need to overcome distinct microenviron-
mental barriers prior to metastasizing to other organs. Invasive
cancers, therefore, could be viewed as a series of adaptations in
phenotype to their microenvironments. All tumor microenviron-
ments are characterized by nutrient deprivation, low pH, and
hypoxia [1]. These changes were linked to perfusion deficits
in solid tumors, which came from rapid tumor growth and
profoundly disorganized vasculature [2]. It has been suggested
that the tumor microenvironment is a unique setting for tumor
progression, which requires genetic adaptations in cancer cells for
further survival and proliferation. Cell stresses induced by the
microenvironment, especially hypoxia [3,4] and reoxygenation
[5,6], might cause these genetic changes.
Regions of hypoxia are a common feature in solid tumors.
Oxygen is a limiting factor because of the imbalance between O2
delivery and consumption [7]. The O2 deficiency is attributed to
insufficient vasculatures and oxygen depletion in successive cell
layers distal to the vessel lumen; simultaneously, there is an
increase in O2 consumption due to the high metabolic rate of
tumor cells. Many studies have reported that hypoxic tumors were
more malignant and resistant to therapy, and thus had a worse
prognosis [8]. This phenomenon has been demonstrated in many
tumor types [9,10].
Moreover, the oxygen concentration within a hypoxic region is
highly variable. Since tumor vasculatures are highly inefficient and
unstable, red blood cells flux to the hypoxic regions, resulting
in reperfusion or reoxygenation [11]. Reoxygenation not only
increases oxygen supply but also induces oxidative stress in the
cells. This oxidative stress could cause damage to cellular ma-
cromolecules and lead to increased genomic instability [12].
If tumor cells survive after exposure to hypoxia/reoxygenation
insults, they may demonstrate increases in malignancy [13],
DNA over-amplification [14], drug resistance [15], and metastatic
potential [16].
Cellular adaptation to hypoxia is well documented, but little is
known about adaptive mechanisms to reoxygenation. Therefore,
we used genome-wide expression microarrays to investigate the
dynamics of transcriptional profiling during reoxygenation in
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e24375MCF-7 breast cancer cells. Our microarray results showed that N-
MYC down-regulated gene 1 (NDRG1) had the maximal response
after reoxygenation. Therefore, we focused on investigating its
functional role in reoxygenation. The functional assays revealed that
cell migration of breast cancer cells during reoxygenation was driven
by down-regulation of NDRG1.L a s t l y ,t h er e g u l a t o r ym o d e lo f
NDRG1 using in silico analysis was proposed for further investigation.
Results
Identification of genes responsive to reoxygenation
MCF-7 human breast cancer cells were incubated under
hypoxia (0.5% O2 concentration) for 24 h and then shifted to
normoxia. Cells were harvested respectively at 0 (hypoxia control),
1, 4, 8, 12 and 24 h after reoxygenation. Each time series was
independently carried out in triplicate. After extracting total RNA,
Illumina Human-6 v3 BeadChips were used to examine the
dynamics of transcriptional profiling upon reoxygenation. Back-
ground-adjusted signals were normalized by a quantile normali-
zation algorithm. In order to identify differentially expressed
genes, Student’s t-test was used to examine the expression levels of
every time point after reoxygenation versus that of time zero. The
genes responsive to reoxygenation were selected by choosing genes
whose mean P-value at a given time point was ,10
24. In total, we
identified 127 genes whose transcript levels deviated significantly
from time zero. Among them, 53.1% were up-regulated and
46.9% were down-regulated upon reoxygenation. Most of these
genes (n=112) were identified at only one time point, but 13 were
identified at two time points, and two genes were identified at
more than two time points.
Next, principal component analysis(PCA) wasapplied to examine
the reproducibility between different replicates and the times when
specificgeneswereactivated. As shown inFigure 1a,replicates of the
same time point aggregated together, indicating high reproducibility
of our data. Also, different time points distributed sequentially
according to the amount of time under reoxygenation. The time
points of 8 h, 12 h, and 24 h were clustered together, indicating
similar gene expression patterns at later time points.
Dynamic responses of gene expression profiling upon
reoxygenation
To quantitatively characterize the O2-responsive genes at each
time point during acclimatization to reoxygenation, statistical
Figure 1. Dynamics of differentially expressed genes during acclimatization to reoxygenation. (a) Principal component analysis (PCA) of
O2-responsive genes in MCF7 cells during 24 h of reoxygenation after hypoxia. The axes are the first two principal components (PC), which can
explain most of the gene expression profiling. Three independent experiments were done at each time point. Different shapes represent different
replicates; different colors represent different time points. (b) Number of O2-responsive genes at each time point during reoxygenation. Both up-
regulated and down-regulated genes are plotted as a function of time. Black bars indicate the number of genes that were identified for the first time,
whereas gray bars indicate the number of genes that were identified at earlier time points. (c) Relative expression profiles of the O2-responsive genes
after shifting to reoxygenation. The expression values of each time point were normalized to that of time zero. The scale bar to the left denotes 20
genes, and the color bar at the bottom indicates the degree of gene expression change relative to time zero. (d) Quantitative RT-PCR validation of the
top ten O2-responsive genes at their respective times of maximal response.
doi:10.1371/journal.pone.0024375.g001
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applied for each gene. The number of genes that were significantly
different (P,0.0001) from the hypoxia control were plotted in
Figure 1b. The numbers of O2-responsive genes, including both
up- and down-regulated genes, were 0 at 1 h, 17 at 4 h, 44 at 8 h,
49 at 12 h, and 35 at 24 h. At 8 h, only 7% of genes (3/44) had
been identified at 4 hours, whereas, 22% of genes (11/49) at 12 h
had been identified at 4 or 8 hours. Thus, this result showed that
transcriptional responses were activated between 8 and 12 h after
reoxygenation, and then diminished at 24 h after reoxygenation.
In order to comprehend the expression profiles of these O2-
responsive genes, their expression values at each time point were
normalized to that of time 0 (Figure 1c). The heatmap showed
that, in general, the intensity of up- or down-regulated genes
increased as cells stayed longer under reoxygenation. Next, the 10
genes with the largest expression changes upon reoxygenation
were selected to validate the microarray results using quantitative
RT-PCR. As shown in Figure 1d, the expression values of these
genes, except one, at the time points with maximal response were
very consistent with the microarray results.
Pathway analysis of genes responsive to reoxygenation
In order to understand which pathways were involved in
adaptation to reoxygenation, pathway analysis was performed
using the NCI-Nature Pathway Interaction Database [17].
Among the 127 identified genes, pathway analysis revealed that,
as expected, the most significantly (P,0.01) enriched pathway
was the HIF-1-alpha transcription factor network, and the second
most significant pathway was validated targets of C-MYC
transcriptional activation (Table 1). Furthermore, to investigate
which pathway was activated at each time point, pathway
analyses were done separately using O2-responsive genes
identified at each time point. The results showed that genes
activated at 8 h were involved in validated targets of C-MYC
transcriptional activation (Table 1). Genes activated at 12 h were
mainly involved in the HIF-1-alpha transcription factor network,
ceramide signaling pathway, and coregulation of androgen
receptor activity.
Down-regulation of NDRG1 promotes cell migration
under reoxygenation
Since NDRG1, whichis regulated bythe MYCsignaling pathway,
had the greatest change in expression following reoxygenation, and
that these reoxygenation genes were enriched in validated targets of
C-MYC transcriptional activation, we wanted to further investigate
the response of NDRG1 to reoxygenation. It was not clear whether
NDRG1 could affect the metastatic ability of tumor cells. Therefore,
transwell assays were conducted to examine the migration ability of
MCF-7 cells at different O2 concentrations. As shown in Figure 2,
the transcript levels of NDRG1 were significantly decreased upon
reoxygenation (Figure 2a), whereas the migration ability of MCF-7
significantly increased (Figure 2b). A western blot confirmed that C-
MYC and N-MYC increased, and NDRG1 decreased, under
reoxygenation conditions (Figure 2c). These results indicate that
NDRG1 can affect migration of transformed cells via the MYC
signaling pathway.
Next, since NDRG1 was down-regulated upon reoxygenation,
we overexpressed NDRG1 in MCF-7 cells to investigate its phy-
siological function. To confirm overexpression, mRNA and
protein levels of NDRG1 were examined by quantitative RT-
PCR (Figure 3a) and western blotting (Figure 3b). The
transcript and protein levels of NDRG1 in NDGR1-transfected
cells were significantly higher than those in cells transfected
with the empty vector control. MCF-7 cells transfected with
NDRG1 or empty vector were then inoculated into transwells
for a second round of cell migration assays under reoxygena-
tion. The results showed that overexpression of NDRG1
significantly (P,0.001) inhibited cell migration under reox-
ygenation (Figure 3c).
Prediction of MYC-associated transcription factors and
hypoxia-related microRNAs in regulating NDRG1
In order to understand the mechanisms regulating NDRG1
expression, we used bioinformatics tools and a literature survey to
predict the binding motifs of MYC-associated transcription factors
in the promoter of NDRG1 and the binding sites of hypoxia-related
microRNAs (miRNAs) in the 39UTR. Using MatInspector and
criteria stated in the Materials and Methods, 170 binding motifs of
transcription factors were identified in the promoter of NDRG1.
Among these transcription factors, MYC-associated transcription
factors that were reported previously were selected. These
transcription factors included E2F-MYC activator, MYC associ-
ated zinc fingers, and E-box binding factors. Their binding motif,
location, and sequence logo are listed in Table S1. These results
indicted NDRG1 might be regulated by these transcription factors,
although more experiments are warranted.
Lastly, the expression levels of miRNAs are known to change
under hypoxia. To investigate the possibility of NDRG1 being
subject to miRNA regulation under different O2 conditions,
binding sites of hypoxia-related miRNAs were searched in the
39UTR of NDRG1. The search criteria allowed one mismatch,
wobble, deletion, or gap between the second and seventh nu-
cleotides of the miRNAs. As shown in Table S2, six binding sites
for the seed regions of four hypoxia-related miRNAs—miR-25,
Table 1. P-values of pathways enriched in differentially expressed genes responsive to reoxygenation.
Enriched pathway
*
Genes expressed at
any time point (n=127) Genes expressed at the following time points:
1h
(n=0)
4h
(n=17)
8h
(n=44)
12 h
(n=49)
24 h
(n=35)
HIF-1-alpha transcription factor network 2.02E-03 -
{ - - 6.27E-03 -
Validated targets of C-MYC transcriptional activation 4.19E-03 - - 3.07E-03 - -
Ceramide signaling pathway - - - - 3.56E-03 -
Coregulation of androgen receptor activity - - - - 5.57E-03 -
*Pathway analysis was done using the NCI-Nature Pathway Interaction Database [17].
{P-value .0.01.
doi:10.1371/journal.pone.0024375.t001
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of NDRG1, suggesting that NDRG1 could be regulated by these
four miRNAs. This result could be used to design experiments
investigating the post-transcriptional regulation of NDRG1 by
miRNAs.
Discussion
Several studies have reported that tumor cells display increased
drug resistance and metastatic potential after exposure to
hypoxia/reoxygenation insults [13,15]. Although cellular adapta-
Figure 2. Down-regulation of NDRG1 correlates with an increase of MCF-7 migration under reoxygenation. (a) Relative expression levels
of NDRG1 under different O2 conditions. The mRNA levels of NDRG1 measured by RT-PCR were first normalized by 18s rRNA, and then compared to
those in normoxia (*P,0.01). (b) Relative migration ability of MCF-7 under different O2 conditions. A transwell assay was used to measure MCF-7
migration. Migration ability was expressed as fold changes relative to normoxia. (c) Western blots of HIF1a, C-MYC, N-MYC, and NDRG1 in hypoxia
and reoxygenation. GAPDH was the loading control.
doi:10.1371/journal.pone.0024375.g002
Figure 3. Overexpression of NDRG1 inhibits MCF-7 migration under reoxygenation. (a) Quantitative RT-PCR analysis of NDRG1
overexpression in MCF-7. The mRNA levels of NDRG1 were normalized by 18s rRNA. EV: empty vector. (b) Western blotting of overexpressed NDRG1.
Protein from whole cell lysates was blotted with NDRG1-specific antibody, and b-actin was the loading control. (c) Relative migration ability of MCF-7
cells after overexpressing NDRG1. Migration ability was expressed as fold changes relative to MCF-7 under reoxygenation.
doi:10.1371/journal.pone.0024375.g003
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adaptive mechanisms to reoxygenation. Here, we examined the
dynamics of genome-wide gene expression during reoxygenation,
and found that the differentially expressed genes were involved
in the HIF-1-alpha transcription factor network and C-MYC
transcriptional activation.
In this study, principal component analysis of the oxygen-
responsive genes showed high reproducibility over time. Based on
the number of O2-responsive genes at different time points, the
active period of transcription in response to reoxygenation appears
to be between 8 and 12 hours. Furthermore, pathway analysis
revealed that the O2-responsive genes at 12 hours were involved in
the HIF-1-alpha transcription factor network, the ceramide
signaling pathway, and coregulation of androgen receptor activity.
It is not surprising that the HIF-1-alpha transcription factor
network was involved in reoxygenation, because it has been
reported in a similar situation, i.e., irradiation. Following radio-
therapy, tumor reoxygenation leads to nuclear accumulation of
HIF-1 in response to reactive oxygen species [18]. One of genes,
namely NDRG1, in the HIF-1-alpha transcription factor network
draw our attention because it had the greatest change in ex-
pression following reoxygenation.
NDRG1 is expressed ubiquitously in tissues stimulated under a
wide variety of stresses and cell growth-regulatory conditions, such
as hypoxia [19,20], DNA damage [21], cellular differentiation
[22,23,24], proliferation and growth arrest [23]. It has been
reported that NDRG1 is strongly up-regulated under hypoxic
conditions. An oncogenic and tumor-promoting role of NDRG1
has also been reported, because it was overexpressed in various
human cancers, including lung, brain, skin, kidney, and breast
cancers [25,26]. However, NDRG1 functioned as a metastatic
suppressor in prostate and colon cancers [24,27]. The contradic-
tory roles of NDRG1 in cancer remained to be clarified, although
they might be explained by its multiple cellular localizations and
complex regulation by diverse physiological and pathological
factors. Recently, Toffoli et al. indicated that NDRG1 can be
induced under intermittent hypoxia to promote cell migration
[28]. Several studies also suggested that NDRG1 is induced by
hypoxia and associated with metastasis, but the regulatory
mechanism of NDRG1 remains elusive and its function under
reoxygenation is still unclear.
NDRG1 had the maximal transcriptional response to reoxygena-
tion in this study, which we felt warranted further investigation.
We observed that the expression of NDRG1 had an inverse
relationship with cell migration upon reoxygenation. These results
implicate NDRG1 as a metastasis suppressor, consistent with the
findings of Maruyama et al. [8]. The discrepancy between our
results and those of Toffoli et al. [28] may be due to different type
of cells and experimental settings.
In order to understand more fully the possible regulatory
mechanisms of NDRG1 under reoxygenation, in silico sequence
analysis was performed to predict DNA binding motifs of
transcription factors in the promoter of NDRG1. Among the
MYC-associated binding motifs identified, zinc finger proteins,
E2F-MYC activator/cell cycle regulators, and E-box binding
factors could affect gene expression [29,30,31,32]. These candi-
date transcription factors can be further validated by constructing
various promoters using luciferase assays. Furthermore, the
expression levels of several miRNAs have been shown to change
in hypoxia [33,34,35]. In particular, miR-210 is induced during
hypoxia via a HIF1-dependent mechanism, and the expression of
miR-210 had a strong correlation with the expression of NDRG1
[34]. Therefore, we hypothesized that the expression of NDRG1
was also regulated by miRNAs. Indeed, the binding sites of the
seed regions of four hypoxia-related miRNAs (miR-106a, miR-93,
miR-25, and miR-210) were identified in the 39UTR of NDRG1.
Therefore, we proposed a working model based on the bioinfor-
matic prediction and literature survey (Figure 4). This model
provides a framework for future biological experiments.
Materials and Methods
Cell culture
Human breast cancer cell line MCF-7 was obtained from
Bioresource Collection and Research Center (Hsiuchu, Taiwan).
MCF-7 cells were maintained in Dulbecco’s modified Eagle
medium (DMEM, Invitrogen Life Technologies, Carlsbad, CA)
containing 1.5 g/L sodium bicarbonate supplemented with 10%
(v/v) fetal bovine serum (Hyclone, Gibco) and with 1% antibiotic
solution (Invitrogen Life Technologies, Carlsbad, CA). For
hypoxic cultures, cells were incubated in a hypoxia chamber
(InVivO2-200, Ruskinn Technology, Leeds, UK) for 24 h with a
Figure 4. The proposed model of NDRG1 regulation by MYC-associated transcription factors and miRNAs in response to changes in
O2 concentration. TSS: transcription start site. White box: transcription factor binding site at + strand; black box: transcription factor binding
site at - strand; gray box: miRNA binding site.
doi:10.1371/journal.pone.0024375.g004
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concentration in the hypoxia chamber was maintained at 0.5%.
After 24 h of hypoxic growth, cells were incubated in a well
humidified incubator with 5% CO2 and 95% room air at 37uC.
Six samples were collected respectively at 0, 1, 4, 8, 12 and 24 h
after reoxygenation. The cells were washed with cold PBS, flash-
frozen in liquid N2, and stored at 280uC for later RNA isolation.
Each experiment was carried out in triplicate.
RNA extraction
Total RNA was extracted with TRIzol Reagent (Invitrogen,
Carlsbad, CA) and was purified by RNeasy Micro cleanup kit
(Qiagen, Valencia, CA) according to the manufacturer’s instruc-
tions. RNA concentration and quality were determined using a
NanoDrop ND-1000 spectrophotometer (NanoDrop Technolo-
gies, Wilmington, DE) and an Agilent 2100 Bioanalyzer (Agilent
Technologies, Palo Alto, CA), which calculates an RNA integrity
number (RIN). Total RNA (500 ng) with A260/A280=1.7–2.1 and
RIN.7.0 were used to synthesize the first strand cDNA via
reverse transcription.
Illumina human whole-genome expression beadchips
The total RNA was primed with the T7 Oligo(dT) primer and
amplified by Illumina TotalPre RNA Amplification Kit (Ambion
Inc., Austin, TX) to synthesize the cDNA containing a T7
promoter sequence. Following the first strand cDNA synthesis,
second strand cDNA was synthesized by converting the single-
stranded cDNA into a double-stranded DNA (dsDNA) template
for transcription. The reaction employed DNA polymerase and
RNase H to simultaneously degrade the RNA and synthesize
second strand cDNA. The double-stranded cDNA then underwent
a clean-up process to remove excess RNA, primers, enzymes, and
salts that would inhibit in vitro transcription. Thereafter, in vitro
transcription was conducted using the double-stranded cDNA as a
template and T7 RNA polymerase to synthesize multiple copies of
biotinylated cRNA. After amplification, the cRNA was mixed with
an equal volume of hybridization buffer and hybridized to
Illumina Human-6 v3 BeadChips (Illumina, San Diego, CA) at
58uC for 16 h. After hybridization, the BeadChip was washed and
stained with streptavidin-Cy3 dye. The intensity of the bead’s
fluorescence was detected by the Illumina BeadArray Reader, and
the results were analyzed using BeadStudio v3.1 software. All data
is MIAME compliant and that the raw data has been deposited in
a MIAME compliant database. Microarray data of this study have
been submitted to the GEO (Gene Expression Omnibus) database
(accession number GSE30019).
Data mining and statistical analysis
After scanning, the intensity data of Illumina Human-6 v3
BeadChips were analyzed by the commercial software PartekH
(Partek, St. Charles, MO) for mRNA expression analysis.
Background-adjusted signals were normalized by a quantile
normalization algorithm, which normalized the probe intensities
based on the intensity distribution among all slides. After
normalization, Principal Component Analysis (PCA), which
reduces high dimensional data into a 2D graph, was utilized to
evaluate the similarity of the gene expression profiles. In order to
identify differentially expressed genes, t-tests examining the
expression levels of every time point after reoxygenation versus
that of time zero were utilized. Genes whose P-value of three
replicates at one or more time points was ,10
24 were identified
and defined as O2-responsive genes. The Genesis program [36]
was used to generate a visual representation of expression profiles.
Furthermore, NCI-Nature Pathway Interaction Database [17] was
applied to identify the biological functions of the differentially
expressed genes.
Overexpression of NDRG1 in MCF-7
The human NDRG1 gene was inserted between the EcoR I and
BamH I sites of the eukaryotic expression vector pcDNA3.1+
(Invitrogen, Carlsbad, CA). MCF-7/NDRG1 cells were created
by transfection of MCF-7 cells with pCDNA3.1+ encoding the
NDRG1 gene using lipofectamine 2000 (Invitrogen, Carlsbad, CA).
MCF-7/NDRG1 cells were then selected by 200 mg/ml of
Zeocine for two weeks. The mRNA expression of NDRG1 was
examined by quantitative real-time PCR, and NDRG1 protein
expression was examined by western blotting.
Quantitative reverse-transcription PCR
Total RNA was extracted using TRIzol Reagent (Invitrogen,
Carlsbad, CA) according to manufacturer’s instructions. Reverse
transcription of total RNA was performed with a High Capacity
cDNA RT Kit (Applied Biosystems, Foster City, CA) using
random primers and 1 mg total RNA as template. The reaction
mixture was incubated at 25uC for 10 min, 37uC for 2 h and 85uC
for 5 sec. Real time PCR was detected by SYBR Green (Sigma)
and was performed using the ABI 7300 (Applied Biosystems,
Foster City, CA). The reactions were performed using the
following program: 40 cycles of denaturing at 95uC for 15 sec
and 1 min of annealing and elongating at 60uC. For each cDNA
sample, an internal control, 18s rRNA, was also measured by the
SYBR Green probe to ensure comparable amounts of cDNA in all
wells. Relative expression of NDRG1 compared with 18s rRNA in
each sample was calculated (gCt) and relative expression of
NDRG1 among samples was determined by calculating the
difference in gCt between samples (ggCt). All measurements
were made in triplicate (5 ng of total RNA per well).
Western blotting
Whole cell extracts were prepared using RIPA lysis buffer
supplemented with 1% Nonidet P-40 (NP-40) and Mini Protease
Inhibitor Cocktail Tablets (Roche, Mannheim, Germany). Cell
debris was collected by centrifugation at 8,000 x g at 4uC for 20
minutes. Protein concentration was measured by the bicinchoninic
acid method (BCA assay), and 20–50 mg protein were loaded on a
10% denaturing sodium dodecyl sulfate polyacrylamide gel. After
electrophoresis, protein was electrophoretically transferred to
PVDF membranes overnight at 55 mA. The membranes were
blocked with Tris-Buffered Saline Tween-20 (TBST) with 5%
non-fat powdered milk at room temperature for an hour.
Detection of specific proteins was done by probing membranes
with primary antibodies in TBS with 0.1% Tween-20 for
1.5 hours at room temperature. These antibody included NDRG1
(AbCam, 1:500), HIF1a (Millipore, 1:1000), C-MYC (Millipore,
1:1000), N-MYC (Millipore, 1:250), and loading control GAPDH
(GeneTex,1:10000) or b-actin (1:5000). After incubation with
the horseradish peroxidase-conjugated IgG secondary antibodies
(1:5000), the immunoreactivity was visualized by enhanced
chemiluminescence with Luminol Reagent (Bio-Rad Laboratories,
Richmond, CA, USA).
Cell migration assay
Migration assays were carried out using 24-well transwell
migration chambers (Corning, Corning, New York, USA) with
8 mm pore size polyethylene membranes. Cells were first starved
24 h and were harvested by Accutase (PAA Laboratories, Linz,
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4 cells/
well in 0.1 ml serum-free DMEM cell solution, and lower
chambers were filled with 0.6 ml DMEM containing 10% FBS
as chemoattractant. Cells were allowed to migrate for 24 h at
37uC. For measuring the migrated cells, 2 mg/ml Calcein-AM
(Trevigen, Gaithersburg, MD, USA)/Cell Dissociation Solution
(Trevigen) was added into the lower chamber. After incubation at
37uC for 60 min, inserts were removed and plates were read at
485 nm for excitation and 520 nm for emission. Cell numbers
were calculated by comparing the absorbance to the standard
curve. MCF-7 cells transfected with empty vector were used as the
control for each experiment.
In silico analysis of NDRG1
To identify potential binding motifs of MYC-associated
transcription factors in the promoter of NDRG1, the MatInspector
program was utilized [37]. Two predefined groups of transcription
factors, including general core promoter elements and vertebrates,
were analyzed in the matrix library version 8.3 using the following
parameters: (1) matrix families were matched instead of individual
sequences; (2) core similarity was at least 0.75; (3) matrix similarity
was optimized. The core region was defined as four consecutive
nucleotides with the highest conservation scores [38]. The core
and matrix similarity were calculated by comparing the query
sequence with the most conserved nucleotide in the matrix. After
identifying the potential transcription factor candidates, the MYC-
associated transcription factors were further selected based on a
literature survey.
For identifying the binding sites of hypoxia-related miRNAs, the
NDRG1 39UTR sequence was downloaded from UCSC’s Genome
browser (http://genome.ucsc.edu/cgi-bin/hgGateway; GRCh37/
hg19 assembly), and was aligned to hypoxia-related miRNAs. The
criteria for searching binding sites of the seed region were allowing
one mismatch, wobble, deletion, or gap between the second and
seventh nucleotides of hypoxia-related miRNAs.
Supporting Information
Table S1 Predicted binding sites of MYC associated
transcription factors in the promoter of NDRG1.
(DOC)
Table S2 Predicted binding sites of miRNAs in the
39UTR of NDRG1.
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